• Specific Year
    Any

NATIONAL HEALTH ACT 1953

Table of Provisions

PART I--PRELIMINARY

  • 1 Short title  
  • 2 Commencement  
  • 4 Interpretation  
  • 6 Delegation  
  • 6A External Territories  
  • 7A Application of the Criminal Code  

PART II--NATIONAL--HEALTH SERVICES

  • 8 Interpretation  
  • 9 Provision of certain medical and dental services  
  • 9A Provision of medical and surgical aids and appliances etc. by the Commonwealth  
  • 9B Provision of vaccines  
  • 9C Arrangements with States for provision of surgical aids and appliances etc.  
  • 10 Arrangements with other Ministers  
  • 11 Arrangements with States  

PART III--CONTINENCE--AIDS PAYMENT SCHEME

  • 12 Continence Aids Payment Scheme  
  • 13 Secretary or Chief Executive Medicare may request information  
  • 14 Reviewing decision whether applicant is eligible for the scheme  
  • 15 Reviewing decision whether participant is eligible for the scheme  

PART VII--PHARMACEUTICAL--BENEFITS

Division 1--Preliminary

Division 1A--Safety net concession cards and pharmaceutical benefits entitlement cards

Division 2--Supply of pharmaceutical benefits

Division 3--Payment for supply of pharmaceutical benefits

Division 3AA--Recovery of payments for the supply of pharmaceutical benefits

  • 99AA Unauthorised payments etc.  
  • 99AB Advances  
  • 99ABA Recovery of amounts for false or misleading information  
  • 99ABB Notice to produce documents  
  • 99ABC Notice of decision to claim amounts as debts  
  • 99ABD Review of decisions to claim amounts as debts  
  • 99ABE Liability for administrative penalty  
  • 99ABF Amount of administrative penalty  
  • 99ABG Notice of administrative penalty and review of assessments  
  • 99ABH Power to obtain information relating to a debt  
  • 99ABI Amounts recoverable once only  
  • 99ABJ Garnishee notices  
  • 99ABK Failure to comply with garnishee notice  
  • 99ABL Recoverable amounts may be set off  

Division 3A--Price reductions

Subdivision A--Preliminary

Division 3B--Price disclosure

Subdivision A--Preliminary
  • 99AD What this Division is about  
  • 99ADA Division does not apply to exempt items  
  • 99ADB Definitions etc.  
  • 99ADBA Meaning of data collection period  
  • Subdivision B--Price disclosure requirements
  • 99ADC The price disclosure requirements  
  • 99ADD When the price disclosure requirements apply  
  • Subdivision D--Consequences for failing to comply with the price disclosure requirements
  • 99ADF Offence for failing to comply with the price disclosure requirements  
  • 99ADG Other consequences for failing to comply with the price disclosure requirements  
  • Subdivision E--Price reduction
  • 99ADH Price reduction based on information provided under the price disclosure requirements  
  • 99ADHA Price reduction for brands listing after end of data collection period  
  • 99ADHB Flow on price reductions for brands of combination items  

Division 3BA--Floor price of a brand of a pharmaceutical item

Division 3C--Guarantee of supply

Subdivision A--Preliminary
  • 99AE What this Division is about  
  • 99AEA Definitions  
  • Subdivision B--Guarantee of supply
  • 99AEB Guarantee of supply  
  • Subdivision C--Brands that are guaranteed brands
  • 99AEC Guaranteed brand: new brand  
  • 99AED Guaranteed brand: first brand to offer a lower price  
  • Subdivision D--Meaning of fails to supply and unable to supply
  • 99AEE Meaning of fails to supply  
  • 99AEF Meaning of unable to supply  
  • Subdivision E--Requirement to notify Minister of failure or inability to supply etc.
  • 99AEG Requirement to notify Minister of failure to supply etc.  
  • Subdivision F--Consequences for guaranteed brands of failure or inability to supply
  • 99AEH Minister's powers if responsible person fails to supply, or is unable to supply, guaranteed brand  
  • Subdivision G--Consequences for other brands
  • 99AEI Minister may increase approved ex - manufacturer price if guaranteed brand delisted  
  • 99AEJ Minister may determine drug is on F1 if guaranteed brand delisted  
  • 99AEK Minister may revoke or vary formulary determination if guaranteed brand delisted  

Division 3CAA--Minimum stockholding requirement

Division 3CA--Discounts and incentives

Division 4--Provisions relating to members of the Pharmaceutical Benefits Remuneration Tribunal

Division 4A--Indexation

Division 4B--Australian Community Pharmacy Authority

  • 99H Interpretation  
  • 99J Establishment of Authority  
  • 99K Functions  
  • 99L Determination of rules by Minister  
  • 99M Powers  
  • 99N Membership  
  • 99P Terms and conditions not provided for by this Act  
  • 99Q Defective appointment not invalid  
  • 99R Remuneration and allowances  
  • 99S Leave of absence  
  • 99T Disclosure of interests  
  • 99U Resignation  
  • 99V Termination of appointment  
  • 99W Meetings  
  • 99X Committees  

Division 4C--Cost recovery

Subdivision A--Preliminary
  • 99YB What this Division is about  
  • Subdivision B--Payment of fees etc. for certain services
  • 99YBA Payment of fees etc. for certain services  
  • Subdivision C--Consequences if fees not paid
  • 99YBB Minister may refuse to exercise certain powers if prescribed fees not paid  
  • Subdivision D--Review of cost-recovery measures
  • 99YBC Review of impact of cost - recovery measures  

Division 4D--Export restriction

  • 99ZH Definitions  
  • 99ZI Restrictions on carriage or consignment of drug like substances  
  • 99ZJ Detention of certain drug like substances being carried out of Australia and retention of related documents  
  • 99ZK Detention of certain drug like substances consigned for export and retention of related documents  
  • 99ZL Examination and inspection powers  
  • 99ZM Detention of some drug like substances and not others  
  • 99ZN Treatment of detained substances and retained documents  
  • 99ZO Treatment by the Chief Executive Medicare of detained substances and retained documents  
  • 99ZP Right of compensation in certain circumstances for substances destroyed  
  • 99ZQ Disposal of forfeited substances  
  • 99ZR Liability for acts done in good faith  
  • 99ZS Guidelines for detention of, dealing with, and disposal of, substances  
  • 99ZT Forfeiture of substances detained under section 99ZJ or 99ZK  

Division 5--General

PART VIIA--REVIEWS--BY ADMINISTRATIVE APPEALS TRIBUNAL

  • 105AA Interpretation  
  • 105AB Application for review by Tribunal  
  • 105AC Statements to accompany notification of decisions  
  • 105AD Application for review by Tribunal of decisions of the Australian Community Pharmacy Authority  
  • 105AE Time limits  

PART VIII--COMMITTEES--OF INQUIRY

Division 1--Preliminary

  • 107 Interpretation  

Division 3--Pharmaceutical Services Committees of Inquiry

  • 113 Pharmaceutical Services Federal Committee of Inquiry  
  • 114 Functions of Federal Committee  
  • 115 Pharmaceutical Services State Committees of Inquiry  
  • 116 Functions of State Committee  
  • 117 Reports not to relate to conduct of PBS prescribers  

Division 4--Provisions applicable to Committees generally

  • 118 Interpretation  
  • 119 Membership of Committees  
  • 119A Acting Member  
  • 120 Chairperson  
  • 120A Vacancies in Committees  
  • 121 Procedure of Committees  
  • 122 Evidence  
  • 123 Proceedings in private  
  • 124 Determination of questions at meetings  
  • 125 PBS prescriber or pharmacist affected by inquiry to be given notice  
  • 126 Summoning of witnesses  
  • 127 Committee may examine upon oath or affirmation  
  • 128 Failure to attend or produce documents  
  • 129 Refusal to be sworn or give evidence  
  • 130 Protection of witnesses  
  • 131 Allowances to witnesses  
  • 132 Protection of members  

PART VIIIA--DATA---MATCHING

  • 132A Definitions  
  • 132B Data - matching by the Chief Executive Medicare  
  • 132C Secretary may disclose therapeutic goods information to the Chief Executive Medicare  
  • 132D Private health insurer may disclose information about hospital or general treatment to the Chief Executive Medicare  
  • 132E Breach of provision of this Part is an interference with privacy  
  • 132F Data - matching principles  

PART VIIIB--COVID---19 VACCINES AND TREATMENTS

  • 132G Provision of COVID - 19 vaccines and treatments  

PART IX--MISCELLANEOUS

  • 133 Effect of prosecution for offence  
  • 133A Territories  
  • 134 Effect of suspension or cancellation of approval or authority  
  • 134A Publication of particulars of certain action taken under this Act  
  • 134B Time for commencing prosecutions  
  • 134C Defence in certain prosecutions  
  • 134D Civil penalty provisions  
  • 134E Obligations not affected by State or Territory laws  
  • 134F Conduct by directors, employees or agents  
  • 135 Right of Commonwealth officers to practise  
  • 135A Officers to observe secrecy  
  • 135AAA Prescribers and approved suppliers must observe secrecy in relation to medicare numbers and expiry dates provided for pharmaceutical benefit scheme purposes  
  • 135AA Privacy rules  
  • 135AB Breaches of the privacy rules  
  • 135AC Authorisation of collection of particular health information  
  • 135B Prosecution of offences  
  • 136 Committees  
  • 136A Filling of vacancies on committees  
  • 137 Moneys from which payments under this Act are to be made  
  • 138 Exercise of Secretary's powers subject to directions of Minister  
  • 138A Telephone access to offices  
  • 139 Judicial notice of signature of Secretary  
  • 139A Evidence  
  • 139C Information with respect to concessional beneficiaries  
  • 140 Regulations  

Navigate